Research in cooperation with the Interdisciplinary Center for Clinical Research at the University of Würzburg / Research within the Clinician-Scientist Programme UNION –CVD (German Research Foundation)
Dr. med. Felipe A. Montellano
|Phone:||+49 931 / 201 47318|
|Fax:||+49 931 / 201 647310|
|since 2020||Resident. Department of Neurology, Würzburg University Hospital|
|since 2017||Research Asssociate. Institute of Clinical Epidemiology and Biometry of the University of Würzburg (MD/PhD Fellow of the Interdisciplinary Center for Clinical Research at the Würzburg University Hospital)|
|since 2016||European Master in Stroke Medicine. Danube-University Krems. Austria (Scholar of the European Stroke Organisation)|
|2015-2017||Medical Doctoral Studies. Institute of Physiology and Pathophysiology. Neurovascular Research Group. Medical Faculty of the University of Heidelberg. (Prof. Dr. Hugo Marti)|
|2014-2015||Resident in Emergency Medicine, Clínica Dávila and Clínica INDISA. Santiago, Chile.|
|2009||Honours Scholarship, Faculty of Medicine of the Universidad de los Andes. Santiago, Chile|
|2007-2013||Medical School. Faculty of Medicine of the Universidad de los Andes. Santiago, Chile.|
Acute stroke therapy, neurocritical care, emergency medicine.
Main Publications in recent years
Systematic review on the effectiveness of mobile health applications on mental health of breast cancer survivors. Journal of Cancer Survivorship [Internet]. 2023;. Available from: https://doi.org/10.1007/s11764-023-01470-6.
Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort. Infection. 2023;:1-16..
Persisting chemosensory dysfunction in COVID-19 - a cross-sectional population-based survey. Rhinology. 2023;61(1):12-23..
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries. Nature [Internet]. 2022;612(7938):E7-E7. Available from: https://doi.org/10.1038/s41586-022-05492-5.
Cardiac dysfunction and high-sensitive C-reactive protein are associated with troponin T elevation in ischemic stroke: insights from the SICFAIL study. BMC Neurology [Internet]. 2022;22(1):511. Available from: https://doi.org/10.1186/s12883-022-03017-1.
Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115-23..
Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549..
Feasibility of platelet marker analysis in ischemic stroke patients and their association with one-year outcome. A pilot project within a subsample of the Stroke Induced Cardiac Failure in Mice and Men (SICFAIL) cohort study. Platelets [Internet]. 2021;33(5):772-80. Available from: https://doi.org/10.1080/09537104.2021.2002834.
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review. Stroke. 2021;52(2):543-51..
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8..
Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study. ESC Heart Failure [Internet]. 2020;8(2):1117-29. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13145.